期刊文献+

MicroRNA-1在小鼠动脉粥样硬化斑块中的表达及通过TGF-β2调控巨噬细胞凋亡功能的研究 被引量:5

Expression of microRNA-1 in atherosclerotic plaque and its regulating effects on macrophage apoptosis via TGF-β2 in mice
原文传递
导出
摘要 目的探讨微小核糖核酸(microRNA)-1在动脉粥样硬化斑块中的表达及通过转化生长因子(TGF)-β2调控巨噬细胞凋亡功能的分子机制。方法实验选用5周龄的雄性Apo E-/-小鼠50只,按实验要求分为对照组(25只)与动脉粥样硬化组(实验组,25只)。实验组小鼠采用高脂喂食以建立动脉粥样硬化模型,对照组小鼠采用正常饲料喂养。造模成功后,实验组及对照组分别取动脉粥样硬化斑块组织及正常动脉组织,采用实时荧光定量PCR(qRT-PCR)检测microRNA-1的表达。培养小鼠内皮细胞、平滑肌细胞及巨噬细胞,并用50 ng/ml氧化修饰低密度脂蛋白(ox-LDL)刺激24 h,应用qRT-PCR技术比较miRNA-1在不同细胞中的表达变化。通过数据库及生物信息学软件预测microRNA-1的靶基因,并利用双荧光素酶报告基因系统进行验证。实验组与对照组分别通过转染microRNA-1 mimics和microRNA-1 mimics的阴性对照至巨噬细胞株后观察其对细胞凋亡功能的影响。结果MicroRNA-1在实验组动脉粥样硬化斑块中的表达比在对照组正常动脉组织中的表达明显增加(P<0.05)。MicroRNA-1高表达于小鼠血管巨噬细胞,而低表达于血管平滑肌细胞及内皮细胞(P<0.05),经ox-LDL刺激后,其在巨噬细胞中的表达量较刺激前明显增加(P<0.05),内皮细胞及平滑肌细胞的表达量无明显差异(P均>0.05)。生物信息学分析发现microRNA-1的靶基因为TGF-β2,并经体外双荧光素酶报告基因系统检测证实。体外细胞功能实验发现microRNA-1能增加巨噬细胞的凋亡,TGF-β2具有抑制其凋亡的功能。结论 MicroRNA-1在动脉粥样硬化斑块中表达上调,其可能通过介导靶基因TGF-β2调控巨噬细胞的凋亡进而参与动脉粥样硬化的发生过程。 Objective To investigate the expression of micro ribonucleic acid (microRNA)-1 in atherosclerotic plaque and the molecular mechanism regulating macrophage apoptosis via transforming growth factor-β2 (TGF-β2) in mice. Meth- ods Fifty ApoE-/- male mice of 5 weeks old were randomly divided into control group ( n = 25 ) and atherosclerosis group ( experimental group, n = 25 ). High fat feeding was given in experimental group to establish atherosclerosis experimental an- imal model, and normal feeding was given in control group. The atherosclerotic plaque tissue and normal artery tissue were respectively taken in experimental group and control group after modeling. The real-time fluorescence quantitative polymer- ase chain reaction (qRT-PCR) was used to detect the expressions of microRNA-I in tissues. After vascular smooth muscle cells, endothelial ceils and macrophages were cuhured in vitro and stimulated by 50 ng/ml of oxidized low density lipopro- tein (ox-LDL) for 24 h,the expressions of microRNA-1 in different cells were detected by qRT-PCR. The target gene of mi- croRNA-1 was predicted by database and bioinformatics software and verified by Dual-Luciferase Reporter Assay System. After being respectively transfected with microRNA-1 mimics and its negative control in macrophage line of experimental group and control group, the influence of microRNA-1 on cell apoptosis function of macrophage was observed. Results Mi- croRNA-I expression in atherosclerotic plaque (experimental group) increased significantly compared with normal artery tissue in control group (P 〈 0.05 ). MicroRNA-1 expression in macrophage was significantly higher than that in vascular smooth muscle cells and endothelial cells (all P 〈 0.05 ). After being stimulated by ox-LDL, microRNA-1 expression level in macrophages increased significantly compared with before stimulating( P 〈 0.05 ) ,while its expression levels in endothe- lial cells and smooth muscle cells remained unchanged ( all P 〉 0.05 ). Bioinformatics analysis showed that the target genes of microRNA-1 might be TGF-β2, whieh was confirmed by Dual-Luciferase Reporter Assay System in vitro. The cell func- tion test in vitro showed that microRNA-1 can increase apoptosis of macrophage,while TGF-β2 can inhibited the apoptosis of macrophage. Conclusion The expression of microRNA-1 is up-regulated in atherosclerotic plaque. MicroRNA-1 might regulate the apoptosis of macrophages via mediating target gene TGF-β2 and participates in the occurring process of athero- sclerosis fhrther.
出处 《中国临床研究》 CAS 2015年第11期1409-1414,共6页 Chinese Journal of Clinical Research
关键词 微小核糖核酸-1 动脉粥样硬化 巨噬细胞 转化生长因子-Β2 凋亡 Micro ribonucleic acid-1 Atherosclerosis Macrophage Transforming growth factor-beta 2 Apoptosis
  • 相关文献

参考文献22

  • 1Voudris KV, Chanin J, Feldman DN, markers in Coronary Artery Disease: et al. Novel Inflammatory Bio- Potential Therapeutic Approa-,,hes [ J ]. Curr Med Chem, 2015,22 ( 22 ) : 2680 - 2689.
  • 2Ungprasert P,Srivali N, Kittanamongkolchai W. Risk of coronary ar- tery disease in patients with ankylosing spondylitis:a systematic re- view and meta-analysis[ J]. Ann Transl Med,2015,3 (4) :51.
  • 3Zhou X, Yang PC. MicroRNA:a small molecule with a big biological impact[ J]. Mi 2012,1 (1) :1.
  • 4Vrijens K, Bollati V, Nawrot TS. MicroRNA as potential signatures of environmental exposure or effect : a systematic review [ J ]. Environ Health Perspect ,2015,123 ( 5 ) : 399 - 411.
  • 5Barrel DP. MieroRNAs : genomies, biogenesis, mechanism, and func- tion[J]. Ce11,2004,116(2) :281 -297.
  • 6Schulte C,Zeller T. MicroRNA-based diagnostics and therapy in car- diovascular disease-Summing up the facts [ J ]. Cardiovase Diagn T- her,2015,5(1 ) :17 -36.
  • 7Nazari-Jahantigh M, Egea V, Sehober A, et al. MicroRNA-specifie regulatory mechanisms in atheroselerosis [ J]. J Mol Cell Cm'diol, 2014 Nov 8. [ Epub ahead of print].
  • 8Tijsen AJ ,van der Made I, van den Hoogenhof MM,et al. The mi- crnRNA-15 family inhibits the TGF[3-pathway in the heart[ J]. Card- iovasc Res,2014,104( 1 ) :61 -7l.
  • 9Kuosmanen SM, Hartikainen J, Hippel~iinen M, et al. MieroRNA pro- filing of perieardial fluid samples from patients with heart failure [ J ]. PLoS One, 2015,10 ( 3 ) : eO 119646.
  • 10Broek M, Samillan VJ,Trenkinann M, et al. AntagnmiR directed a- gainst miR-20a ~stores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced puhnonary hypertension [ J ]. E ur Heart J, 2014,35 ( 45 ) : 3203 - 3211.

同被引文献95

  • 1李志强,郑兴.线粒体DNA损伤在冠心病诊断中的意义[J].中国心血管病研究,2006,4(10):787-789. 被引量:4
  • 2Ali A.Rizvi.Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome and type 2 diabetes[J].Chinese Medical Journal,2007(21):1918-1924. 被引量:27
  • 3Ashfaq F, Goel PK, Sethi R, et al. Lipoprotein a levels in relation to se- verity of coroniry artery disease in North Indian patients [ J ]. Heart Views,2013,14( 1 ) :12-16.
  • 4Kaptoge S, Di Angelantonio E, Pennells L, et al. Emerging Risk factors Collaboration. C-r-eactive protein, fibrinogen, and cardiovascular dis- ease prediction[ J]. New Engl J Med,2012,367 (14) : 1310-1320.
  • 5Li SB, Yang F. Correlation between plasma Lipoprotein-associated phospholipase A2 and peripheral arterial disease [ J ]. Exp Ther Med, 2013,5(5) :1451-1455.
  • 6Rallidis LS,Tellis CC. Lipoprotein-associated phospholipase A2 bound on high density li-poprootein is associated with lower risk for cardiac death in stable coronary artery disease patients : a 3-year follow-up [ J ]. J Am Coll Cardiol,2012,60(20) :2053-2060.
  • 7Kakkos SK. The emerging role of lipoprotein-associated phospholipase A2 in cerebrovascular disease [ J ]. Eur J Vasc Endovasc Surg,2012, 43(2) :160.
  • 8Bot I, Shi GP, Kovanen PT. Mast cells as effectors in atherosclerosis [ J ]. Arteriosclerosis Thrombosis & Vascular Biology, 2014,35 ( 2 ) : 265 -271.
  • 9Willems S. Mast cells in human carotid atherosclerotic plaques areas- sociated with intraplaque microvessel density and the occurrence of future cardiovascularevents [ J 1. European Heart Joumal, 2013,34 (48) :3699-3706.
  • 10孔慧.急性心肌梗死患者血清类胰蛋白酶水平与吸烟的关系[D].杭州:浙江大学,2015.

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部